<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 155 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page154.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=155">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 155 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 155</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=155"><img src="../thumb/155.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>124 / 2020-04                                                    Cardio-Vascular Agents -  7.4.1 / 7.4.2
                                                                            rd
   Indications: Treatm.& prophylax.of ang.pect.  PHARMA-Q VERAPAMIL INJECTION 5 mg/2 ml Pharma-Q [P/S]  signific. 1st & progress.to 2nd /3  degree block, hypertroph. card.
   (S3) CAPS, X/7.1./0102       Verapamil HCl.                myopath., pulm.oed and/or sev.hypotens., imp. hepat./ren.funct.,
   826863-019: 5 mg, 100, R63,53  Indications: IV indic.where oral ther.not feas.in supraventr.tachyar-  attenuat.neuromusc. transmiss., poss.digit.intoxic., do not admin.
   Dosage: Init.10 mg 3xdly.then titrat.over 7-14 days to control angin.  rhythm., managem.of class.& variant ang.pect., hypertens.   disopyramide within 48 hrs.prior to/24 hrs.aft. verapamil, concom.
   sympts. Usual dos: 10-20 mg 3xdly.  (S3) INJ, 29/7.1.4/0666. 5 mg/2 ml  quinidine in hypertroph. cardiomyopathy.
   Contraindications: Safety in pregn.& lactat. not est., hepat.  703896-001: 10x 2 ml amps, R179,54  Drug interactions: Cumulat.effs.on heart rate with ß-block., incr.
   impairm., GI/oesophag.obstruct. hist., inflamm.bowel.dis., childr.  Dosage: IVI giv.und.contin.ECG monit.esp.in infancy.  digoxin serum conc., intens.BP low.eff.of other anti-hypertens., ad-
   Side effects: Headache, GI disturbs., flush., lethargy, dizzin., periph.  Adults: 5-10 mg giv.IV over per.of 30 sec.follow.by furth.5 mg if   dit.effs.on AV node conductiv./myocard.contractil./repolarisat.& on
   oed., allerg.reacts., hypotens., palpitat., ang.pain precipitat., hypers-  necess.aft.5-10 min.interv.  negat.inotrop.eff.with flecainide, quinidine plasma lev.incr., low.of
   ens. reacts., gingiv.hyperplas., syncope, tachycard., perspirat., nerv-  Childr: Suggest.IV dos. Neonates: 0,75-1 mg. Infts: 0,75-2 mg.   serum Li lev.& incr. sensitiv. to Li effs., conc.of carbamazepine incr.,
   ousn., MI, arthralg., insomn., “steal eff”, hyperglycaem.  Childr.1-5 yrs: 2-3 mg. 6-15 yrs: 2,5-5 mg. Small.dos.may be adeq.   rifampicin.reduc.oral bioavail., phenobarbit.may incr. clear., ciclospor.
   Special precautions: Bite caps.& keep contents in mouth for more   Stop inj.when respons. obtain.  ser.lev.incr., excess.CV depress. with inhalat.anaesthet., effs.of neu-
   rapid onset of act., monit.BP, poor card.reserve, diabet., discont.if is-  Contraindications: Hypotens.assoc.with cardiogen.shock, mark.  romusc. block.agents.potent.
   chaem.pain experienc.        bradycard., part./compl. atrioventric.block, uncompensat.HF, sick-si-
   Drug interactions: Enhanc.anti-hypertens.eff.of ß-adrenoceptor   nus syndr.unless pacemak.fitt., atrial flutt./fibrillat., access.pathway
   block.agents., interacts.poss.with other meds.shar.same metabol.  with anterogr.conduct.eg.WPW syndr., safety in pregn.not est., lac-
   pathway & enzyme induc./inhibit.  tat., IV in digital. toxic., disopyramide within 48 hrs bef.or 24 hrs.aft. 7.4.2   Beta-receptor blockers
   BIO-NIFEDIPINE XL, Biotech [P/S]  Side effects: Sympt.hypotens.in normotens.pts., pulm.oed.&/sev.  ADCO-ATENOLOL, AI Pharm Ltd [PWR]
                                hypotens./sinus bradycard./AV block/sinus arrest in pts.with hyper-
   Nifedipine                   troph. cardiomyopathy, atrioventric./sinoatr.nodal funct. depress., 1   st
   Indications: Mild to mod.hypertens., prophylax.of chron.sta-  degr.AV/SA block, trans.bradycard, nod. escape rhythms, precipit./  Atenolol.
                                                              Indications: Ang.pect., hypertens.
   ble ang.pect.                worsen. HF, trans. asystole., constip., nausea, dizzin., flush., head-
   (S3) XL TABS, 43/7.1/0558, 0559  ache, abnorm.liv.funct.   (S3) TABS. W/5.2/115, 116.
                                                              786578-017: 50 mg, 30, R21,78
   718083-001: 30 mg, 30, R108,62  Special precautions: May precipit./worsen HF, excret. in breast
   718085-001: 60 mg, 30, R155,85  milk, sev.(L) ventric.dysfunct./any degr. thereof if receiv.ß-adrenerg.  786586-001: 100 mg, 28, R33,16
                                                              Dosage: Ang.pect: 100 mg dly.as sngl./div.dos.
   Dosage: Swallow whole with glass of fluid at approx.24 hr.interv.  st
   pref.in morn.                blocks, contr. mild. ventric.dysfunct.1  with digital.&/diurets. bef. init.  Hypertens: 100 mg dly as sngl.dos.
                                                              Contraindications: 2nd & 3rd degr.heart block, myocard.depress.
                                treatm., hypertroph.cardiomyopathy, monit. for abnorm.PR interv.pro-
   Recomm.dos: 30 mg once dly. Incr.if necess. accord. to indiv.requirem.
   to max.90 mg once dly.       longat., imp. hepat./ ren.funct., poss.digital.toxic., decr. neuromusc.   agents, verapamil ther., prolong. fast., metabol.acidos., CF (unless
                                                              signs of fail. controll.with digital.&/diuret.), concom.ether, chloro-
                                transmiss. in Duchenne’s musc. dystroph., reduc.dos.in pts.with atten-
   Contraindications: Pregn.& lactat., porphyr., CV shock., aort.stenos.,
   unstab.ang., dur./within 1 mnth.of MI, hepat.impairm., GI/oesophag.   uat. neuromusc.transmiss., signfic.hypotens.with concom.quinidine   form, cyclopropane & trichloroethylene.
                                                              Side effects GI disturbs., CNS eff., CV effs.incl. heart block., periph.
                                in hypertroph.cardiomyopathy, monit. with concom.Li ther., WPW or
   obstruct. hist., decr.oesophag.lumen, inflamm. bowel.dis., concom.
   rifampicin, childr., men involv. in in vitro fertilisat.  Low-Ganong-Levine syndr., poss. dos. reduct./discont.if mark./ pro-  vasc.dis.exacerbat.incl.gangr. precip., Raynauds & paraesthes., im-
                                gress.AV block occurs, inhalat.anaesthet.
   Side effects: Dizzin., flush., headache, hypotens., periph./fac.oed.,   pot., hypoglycaem., skelet.musc. weakn., vis.disturbs., bronchosp.,
   tachycard., palpitat., asthen, malaise, pain, dry mouth, hypersens.  Drug interactions: Addit.negat.effs.on heart rate/ AV conduct.&card   bld.disords., skin rash, floppy inft. syndr. if giv.shortly bef.birth/dur.
                                contractility with ß-adrenerg. blocks., incr.digoxin plasma lev., intensif.
   reacts., chest pain, ang.pect., vasodilat., CV disord., GI disturbs., hy-  labour, excret.in breast milk.
   perglycaem., weight loss, insomn., nervousn, paraesthes., somnol.,   BP low.eff.with other antihypertens., addit. effs.on myocard.contrac-  Special precautions: Asthma, bronchit., chron. resp. dis., brady-
                                til. /AV conduct./ repolarisat.with flecainide, quinidine plasma lev.
   vertigo, anx., hyposthes., sleep disord., trem., leg/musc.cramps &   card.(&lt;50 beats/min), periph.vasc. dis., phaeochromocyt. without
   pain, arthralg., joint disord., myalg., dyspn., epitax., nas.congest.,   incr., low.ser.Li lev.& incr.sens.to Li effs., carbamazepine conc.incr.,   concom.a-adrenocept. block, safety dur.longt.admin.not est., peri-
   skin & subcut.disords., dysur., urin.freq., eye pain, abnorm./blurr.vis.,   rifampicin mark. reduc. oral verapamil bioavailabil., phenobarbitone   op.period., clonidine transf., grad.withdr., ren. dysfunct., lactat., poss.
   eye pain, bld dyscras., gynaecomast., erect.dysfunct.  incr. verapamil clear., cyclosporin ser.lev.incr., may potent. activ.of   digitilisat.of cert.pts.on longt. ther.esp.those in whom CCF may devel.
   Special precautions: Poss.sev.hypotens.& isolat. HF with   neuromusc.block.agents.  Drug interactions: Concom.hypoglycaem. agents, phenothiaz.&
   concom.ß-recept. blocks., diab.mellit., dialys.pts.with malign.hyper-  RAVAMIL SR, (Biopharma Div) Merck [P/S]  var.anti-arrhythm.agents poss.life threaten.conseq., eff.dimin.by ß-
   tens.& irrevers.kidn.fail with hypovol., GI obstruct.sympts. in GI dis-  Verapamil HCl.  adrenerg. stimulat. agents, hypotens.eff.poss.revers.& periph. vaso-
   ord.hist., poor card.reserv, ang.pect.with hypoten., HF, Kock pouch  Indications: Ang.pect., mild to mod.hypertens., supraventric.tachy-  constrict.eff.enhanc.by a-adrenerg. stimulat. agents, eff.enhanc.by
   Drug interactions: BP low.act.enhanc.by other antihypertens.meds.,   dysrhythm., prophylax.of supraventric.relapses aft.electrocardiovers.  adrenerg.neurone block. agents & diuret., card.eff.of digit.enhanc./
   meds.inhibit./induc. cytochrome P450 3A4 syst.may alter first pass/   (S3) SR TABS. 29/7.1/0357.  dimin., eff.of myocard.depress.agents poss. enhanc.
   clear., rifampicin low.effic., incr. plasma conc.with /quinupristin/dal-  819573-019: 240 mg, 30, R216,30  B-BLOCK, (Unicorn) Be-Tabs [PWR]
   fopristin/ cimetidine/ cisapride/macrolide antibiot./fluoxetine/ am-  819573-027: 240 mg, 100, R721,04  Atenolol.
   prenavir/indinavir/nelfinavir/ritonavir/saquinavir/grapefruit juice/   Dosage: Ang.pector.& supraventric. dysrhythm: ½-1 tab.12 hrly.  Indications: Ang.pect., hypertens., MI early intervent. in ac.phase.
   ketoconazole/ itraconazole/fluconazole/nefazodone & valproic acid,   Hypertens: 1 tab/day pref.in morn., may be incr.aft. 7 days if re-  (S3) TABS. 31/5.2/0332, 32/5.2/0670.
   poss.decr.plasma conc.with carbamazepine & phenobarb., reduc.di-  spons.undesir.to 1 tab in morn. & ½ tab at night. Max.recomm.  704653-001: 50 mg, 30, R20,10
   gox.clear., reduc.eff.with phenytoin, poss.dos.reduct.with quinidine,   dos: 1 tab 12 hrly.  704651-001: 100 mg, 30, R33,15
   poss.tacrolimus dos.reduct., diltiazem reduc.hepat.metabol.& dos.  Contraindications: Hypotens.assoc.with cardiogen. shock, heart   Dosage: Ang.pect: 100 mg dly.as sngl./div.dos.
   reduct.for both agents poss.reqd.  fail., retard.AV conduct., ac.stage of MI, sick-sinus syndr., lactat.  Hypertens: 100 mg dly as sngl.dos. May be combin. with other
   CIPALAT RETARD, Cipla Medpro [P/S]  Side effects: GI disturbs., headache, fatig., palpit., 1st & 2nd AV   antihypertens.agents.
                                                                                rd
                                                                              nd
   Nifedipine.                  block, SA block, flush., dizz., urticar., skin rash, symptomat.hypotens.  Contra-indications: Pregn.& lactat., 2 /3  degree heart block, con-
   Indications: Chron.stable ang.pect.prophylax., mild to mod.hypertens.  in normotens. pts., exacerbat.of arthrit., incr.urinat., gum burn., mild   com.verapamil., aft. prolong. fast., metabol.acidos., CF (unless signs
   (S3) RETARD TABS, 32/7.1/0660  trem., sev.facial pain.     of fail.controll. with digital.&/diuret.), uncontroll.CF (excl.that due to
   864153-007: 20 mg, 60, R74,00  Special precautions: Cross.placent.barr., discont. breast feed.,   hypertroph.obstruct. cardiomyopathy), cardiogen. shock.
   Dosage: Admin.bef.meals. Recomm.dos: 20-40 mg 2xdly. Dos.interv.  contr.mild ventric. dysfunct.1st with digit.&/diuret., access.bypass   Side-effects CV effs.incl.CHF & bradycard., HF/ heart block, reduc.
   about 12hrs., not less than 2-4 hrs.  tract, mark.1st. degr.AV block/ progr.developm.to 2nd & 3rd-degr.   periph.circulat., periph.gangrene precip., CNS effs., neuropsych.
   Contraindications: Pregn.& lactat., CV shock, hepat./ren.funct.im-  block, hypertroph.cardiomyopathy, imp. hepat./ren.funct., attenuat.  disords., GI disturbs., bld.disords., skin rash., revers.alopec., prurit.,
   pairm., concom.rifampicin, porphyr.  neuromusc. transmiss., do not admin.disopyramide within 48 hrs.   paraesthes., periph.neuropathy, myopathies incl.musc.cramps, vis.
   Side effects: Headache, flush., dizz., hypotens., oed., dyspn., polyur.,   prior to or 24 hrs.aft.verapamil, avoid concom. quinidine in hyper-  disturbs., bronchosp., pneumonit., pulmon. fibros., pleurisy, lupus
   weakn., warm feel., tiredn., GI disturb., incr. micturit.freq., lethargy,   troph.cardiomyopathy, titrate concom. inhalat.anaesthet.careful.to   like syndr., male impot., scleros.peritonit., retroperiton. fibros., hypo-/
   eye pain, blurr.vis., depress., paraesthes., skin reacts.incl. exfolat.der-  avoid excess. CV depress.  hyperglycaem., sex.impot
   matit., unilat.gynaecomast., paradox. ischaem.chest pain incr., ang.ex-  Drug interactions: Poss.addit.negat.eff.with ß-adrenerg.block.., incr.  Special precautions: Asthma, bronchit., chron. resp. dis., brady-
   acerbat.with sudd. withdraw., MI, syncope, tachycard., palpitat, per-  digox.plasma lev., intens.BP low.eff.of other anti-hypertens., addit.eff.  card.(&lt;50 beats/min), periph.vasc. dis., Raynaud’s phenomen.,
   spirat., nervousn., incr.ang.freq., fev., hypersens. reacts., revers.gingiv.  on myocard. contractility, AV conduct., & repolarisat. with flecainide,   pts.with hist. anaphylact. reacts.may have more sev.react.on rep.
   hyperplas., incr. proteinur.& ren.dysfunct.in diab. pts.with ren. insuffic.  low.of ser.Li lev.& incr.sensitiv.to Li effs., conc.of carbamazepine incr.,   chall.& be unrespons.to adrenaline, elderly, ren. dysfunct., peri-op.
   Special precautions: Teratogen.in anim., grad. withdr., monit.BP   rifampicin may mark.reduc.bioavail., phenobarbit.may incr. clear., cy-  period, digitilisat.in longterm ther.where CCF may devel., Ca chann.
   reg.esp.with concom. antihypertens. ther., sev.hypotens.with systol.  clospor.serum lev.incr., poss. potent.activ. of neuromusc.block.agents.  block.& atenolol.not to be admin.within 48 hrs.of discont.the other,
   BP less than 90mm Hg, manifest HF & sev.aortic stenos., dialys. pts.   SPEC NIFEDIPINE, Specpharm (Pty) Ltd  accumulates in breast milk, poor card reserve, phaeochromocyt.req.
   with malign.hypertens.& irrevers. kidn.fail.with hypovolaem., imp.liv.  See Section 7.3.7  concom.a-adrenerg. block.ther., may mask hyperthyroid. sympts.,
   funct., antidiabet.ther., monit.with oestrog./ß-blocks./ NSAID ther.  myasthen.grav.unmask., poss.aggrav. psorias., grad.discont., physic.
   esp.indomethacin, concurr. disopyramide.  VERAHEXAL 240 SR, Sandoz [P/S]  activ.limit.dur. discont.period, concom verapamil in pts.with imp.ven-
   Drug interactions: Act.of BP low.preps.enhanc., alcoh.inhibit.me-  Verapamil HCl.  tricul.funct./clonidine transf., avoid. anaesthet. agents caus.myocard.
   tabol., enhanc.hypotens.eff.with inhalat.anaesthet., incr.ser.Ca conc.  Indications: Mild to mod.hypertens., ang.pect. prophylax., su-  depress., haemodialys.
   from Ca supplem. reduc.respons., concom.highly prot.-bound meds.,   praventric.tachydysrhythm., prophylax. of supraventric.relapses aft.   Drug interactions: Incr.risk myocard.depress.& hypotens.with
   antihypertens.eff.potent.by cimetidine., sympathomimets.reduc.an-  electrocardiovers.  anaesthet.agents, hypoglycaem. agents/phenothiaz.& var.anti-
   ti-hypertens. eff., serum quinidine lev.suppress., reduc.digox. clear.,   (S3) SR TABS. 31/7.1/0637  arrhythm.agents poss. life threaten. conseq., negat. inotrop.effs.of
   clear.decr.by diltiazem.     700071-003: 240 mg, 30, R166,43  verapamil & diltiazem.exaggerat.partic.in imp. ventricul. funct./SA
                                                              & AV conduct.abnorm., poss. decr.hypotens.eff.with.prostagland.
   CIPALAT XR, Cipla Medpro (Pty) Ltd  700071-006: 240 mg, 100, R555,18  synthet.inhibit.drugs., eff.counteract.by sympathomimet.agents, eff.
                                Dosage: Hypertens: 1 tab.dly.pref.in morn. If desir. respons. not
   See Section 7.3.7            obtain.within 7 days dos.may be incr.to 1 tab.in the morn.& ½ tab.at   dimin.by ß-adrenerg.stimulat.agents
   FEDALOC SR, Pharma Dynamics (Pty) Ltd  night. Recomm. max.1 tab.12 hrly.  BILOCOR, Pharma Dynamics (Pty) Ltd
   See Section 7.3.7            Ang.pect.& supra-ventric. dysrhythm: ½-1 tab 12 hrly.  nd  See Section 7.3.3
                                Contraindications: Hypotens.assoc.with cardiogen. shock, HF, 2
   GITSALAT, Sanofi-Aventis (Pty) Ltd  & 3  degr.AV block., ac. stage of MI, sick-sinus syndr., pregn., lactat.  BIO-ATENOLOL, Biotech [PWR]
                                  rd
   See Section 7.3.7            Side effects: Symptomat.hypotens.in normotens. pts., incr.transami-  Atenolol
   NORVASC, Pfizer Laboratories (Pty) Ltd  nas.&/or alkaline phosphat.& bilirub., GI disturbs., headache, fatig.,   Indications: Hypertens., ang.pect., to improve CV mortal.in clinic.
   See Section 7.3.7            palpit., worsen. HF, trans.asystole, 1st & 2nd AV & SA block, brady-  stable pts.who surviv.ac.MI phase
                                                              (S3) TABS, W/5.2/0439, 0440
                                card., dizz., urticar., skin rash., flush.
   PENDINE, Activo Health       Special precautions: HF, contr.mild ventr. dysfunct. 1st with dig-  826898-025: 50 mg, 30, R21,95
   See Section 7.3.7            it.&/diuret., atrial fibrillat., poss. dos.reduct./discont.on developm.of   826901-034: 100 mg, 30, R38,16</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page154.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>
             </td>
             <td width="35%"><a href="page156.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page156.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
